2؉ plays a critical role in many cellular functions although its mode (s) of regulation is unclear. This study shows that the metabotropic glutamate receptor, mGlu5, mobilizes nuclear Ca 2؉ independent of cytosolic Ca 2؉ regulation. Immunocytochemical, ultrastructural, and subcellular fractionation techniques revealed that the metabotropic glutamate receptor, mGlu5, can be localized to nuclear membranes in heterologous cells as well as midbrain and cortical neurons. 
Changes in nuclear Ca
2ϩ play an integral role in cellular functions such as protein import, apoptosis, and gene transcription (1, 2) . Nuclear Ca 2ϩ may be generated from a number of sources including diffusion of cytosolic Ca 2ϩ waves through nuclear pore complexes (2) . Because the outer nuclear envelope is continuous with the endoplasmic reticulum, which serves as an internal store of Ca 2ϩ , rises in nuclear Ca 2ϩ may also be attributable to a luminal source (3) . Recent studies using high speed imaging of intracellular Ca 2ϩ have shown that waves of Ca 2ϩ can invade the nucleus by emptying intracellular stores (4) . Calcium release from internal stores is controlled by various channels including the inositol 1,4,5-trisphosphate (IP 3 ) 1 receptor and ryanodine receptor families (5, 6) both of which are present on nuclear membranes (7, 8) . Calcium itself is an activator of these channels (1) although nuclear IP 3 can stimulate IP 3 receptors located on the inner nuclear membrane and cADP ribose has been shown to activate nuclear ryanodine receptors (7, 8) . Luminal Ca 2ϩ is refilled at least in part by the nuclear Ca 2ϩ -ATPase (9, 10) located on the outer nuclear membrane. Thus, although signals originating at the plasma membrane may be transmitted to the nucleus (4), the presence of specific Ca 2ϩ transporters on the nuclear envelope argues for a nuclear Ca 2ϩ regulatory system that may be independent of cytosolic Ca 2ϩ regulation. Many components of G protein signaling pathways are also found in the nucleus or associated with nuclear membranes. These include phospholipase C isozymes (11, 12) , nuclear inositol phosphates (12, 13) , DAG (13) , PKC isozymes (14) , adenylate cyclase (15) , regulators of G protein signaling (RGS proteins; Refs. 16 and 17) as well as heterotrimeric G proteins themselves (18) . These observations raise the possibility that plasma membrane-based signaling components may also serve a similar function at nuclear membranes. Indeed, several recent reports are consistent with the notion that nuclear G protein-coupled receptors directly modulate nuclear signal transduction pathways. For example, angiotensin II receptors were found on hepatocyte nuclear membranes (19) , opioid binding sites were described on ventricular myocardial nuclei (20) and endothelin-1 receptors were reported on vascular smooth muscle nuclear membranes (21) . Direct evidence of nuclear receptor G protein signaling has also been demonstrated for prostaglandin receptors which, when stimulated, cause rapid Ca 2ϩ influx into the nucleus (22, 23) . Taken together, these data suggest that nuclear signaling may represent a versatile, independent system by which nuclear function is regulated.
Glutamate, the major excitatory amino acid in the brain, activates a wide range of both ion channels and G proteincoupled receptors. The latter, so-called metabotropic glutamate receptors, are widely expressed throughout the central nervous system where they are thought to be involved with many critical processes including neuronal development, learning and memory, and neurodegeneration (24) . Structural and functional criteria have further subdivided the metabotropic receptors into 3 groups; Group I include mGlu1 and mGlu5 receptors, which stimulate PLC activity and release Ca 2ϩ from cytoplasmic stores (24, 25) . Calcium can also modulate the glutamate sensitivity of Group I receptors (Refs. 26 -28 ; but see Ref. 29) .
Although mGlu1 and mGlu5 utilize similar signal transduction pathways, activation of mGlu1 receptors elicits a single Ca 2ϩ peak (30) whereas mGlu5 activation leads to a marked oscillatory response in heterologous cells (30 -32) as well as neocortical, hippocampal (33) , and spinal cord neurons (34) . It has been estimated that 90% of the Ca 2ϩ oscillations that occur spontaneously in immature cortical neurons can be ascribed to mGlu5 receptors (33) . Inasmuch as Ca 2ϩ oscillations can differentially affect gene expression (35) , they play an important role in the control of developmental events.
Electron microscopic studies have shown that Group l mGlu receptors can be localized at the edge of asymmetric and in symmetric synapses (36 -38) as well as extrasynaptically (38, 39) in a variety of brain regions. In addition, mGlu5 and mGlu1 have also been localized intracellularly where they are predominately associated with the endoplasmic reticulum (ER) or nuclear membranes (36 -38) . Because these receptors are activated by contact with their endogenous ligands at the cell surface, intracellular accumulation is presumed to represent either receptor sequestration and/or "extra" receptors poised to be inserted into the membrane if needed. Here, we show that activation of nuclear mGlu5 receptors can trigger Ca 2ϩ oscillations in both the cytoplasm as well as isolated nuclei. These data suggest that nuclear receptors can independently activate rises in nuclear Ca 2ϩ and that intracellular receptors can have functions other than serving as spare receptors.
EXPERIMENTAL PROCEDURES
Cell Culture and Plasmids-HEK cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (Invitrogen) as described (32) . Midbrain cultures were prepared and maintained exactly as described (40) . The mGlu5 stable cell line was generated using standard transfection techniques followed by repetitive rounds of limiting dilution (32) . The N-terminal HA-tagged mGlu5 clone was generated previously (32) . An expression plasmid containing the full-length clone of GABA B2 was obtained from Dr. Bernhard Bettler (Novartis, AG, Basel, Switzerland). A GFP-tagged G q plasmid was obtained from Dr. Thomas Hughes (Yale, New Haven, CT).
The Semliki Forest virus vector used to deliver mGlu5 into postmitotic neurons was obtained from Dr. Kenneth Lundstrom (Hoffman-La Roche, Basel, Switzerland). This cloning vector, pSFV(PD) contains two point mutations inhibiting cytotoxicity (41) . The construct, pSFV(PD)-mGlu5, was created using standard cloning methodologies. SFV stocks were produced as described (42) . Briefly, in vitro transcribed RNA molecules from pSFV(PD)-mGlu5 were cotransfected via electroporation into BHK cells with the pSFV-Helper2 RNA. Viral stocks were harvested 18 h later and filter-sterilized. Viral stocks were subsequently activated with ␣-chymotrypsin (Sigma) and the reaction terminated with aprotinin (Sigma) as described (42) . Approximate viral titers were determined by transduction of HEK cells with serial dilutions of SFV(PD)-mGlu5 followed by immunocytochemistry 1 day later.
Subcellular Fractionation-The mGlu5 receptor stable cell line was grown to near confluency, washed twice with phosphate-buffered saline and harvested by scraping followed by centrifugation. Postnatal day 3 mouse forebrains were processed by mincing tissue on ice with a razor blade into 1 mm cubes. Tissue cubes or cellular pellets were resuspended in 10 volumes of Buffer "A" medium containing 2.0 mM MgCl 2 , 25 mM KCl, 10 mM HEPES (pH 7.5), and protease inhibitors (Complete Tablets; Roche Applied Science, Indianapolis, IN). After swelling for 10 min on ice, cells were homogenized in a Wheaton glass homogenizer using 15 strokes with a "B" pestle. The homogenate was filtered through 3 layers of sterile gauze and centrifuged at 1000 ϫ g for 10 min. The nuclear pellet was resuspended in 3 ml of Buffer N containing 0.25 M sucrose in buffer A. Resuspended nuclei were layered over 2 ml of medium containing 1.1 M sucrose in buffer A, and then recentrifuged at 1000 ϫ g. This step was repeated twice. The final nuclear pellet was resuspended in SDS sample buffer as described (32) . The supernatant from the first pellet was concurrently further fractionated by centrifugation at 35,000 ϫ g for 40 min. This second supernatant represented soluble, cytoplasmic proteins whereas the high speed pellet contained plasma membrane proteins. Aliquots from each fraction were used for gel electrophoresis as well as membrane binding. Protein concentrations were determined using the Bradford assay (Bio-Rad, Richmond, CA).
Immunocytochemical and Confocal Microscopic Studies-Cells for immunocytochemical and confocal microscopic studies were grown on poly-D-lysine-treated glass coverslips, 8-well chamber slides, and/or dishes with 35-mm glass grids (Mat-Tek, Ashland, MA). Fixation, blocking, and antibody incubation were as described (32) with the exception of experiments permeabilizing membranes with digitonin. In the latter cases, permeabilization, fixation, staining, etc. were performed exactly as described by Watkins et al. (43) . Primary antibodies included affinity-purified anti-C-terminal mGlu5 (1:300; 44) and anti-mGlu1a (1:300; 45), polyclonal anti-HA (1:250; Babco, Berkeley, CA), monoclonal antilamin B 2 (1:100; Zymed Laboratories, San Francisco, CA), monoclonal anti-ryanodine receptor (1:200; MA3-925, Affinity Bioreagents, Inc., Golden, CO), and polyclonal anti-GFP (1:500; Chemicon, Temecula, CA). GABA B2 was detected with rabbit antibody AbC22 (1:1000; 46). Secondary antibodies included goat anti-rabbit and/or anti-mouse Cy3 (both at 1:300; Jackson ImmunoResearch, West Grove, PA) and goat anti-mouse Alexa 488 (1:300; Molecular Probes, Eugene, OR) or goat anti-rabbit Alexa 488 (1:2000; Molecular Probes). Confocal microscopy was performed using an Olympus Fluoview microscope and associated software.
Electron Microscopy-Adult Long-Evans rats were perfused, fixed, and sectioned exactly as described (47) . Thin sections were mounted on nickel grids and staining was performed on drops of rabbit anti-mGlu5 antibody followed by a goat anti-rabbit secondary conjugated to 15-nm gold particles (1:25; Amersham Biosciences). Sections were stained with uranyl acetate and lead citrate, and ultrastructural analysis was performed in a Jeol-100 electron microscope.
[ 3 H]Quisqualate Binding Assay-Nuclear and plasma membrane fractions were prepared as described. Both pellets were subsequently washed three times in 2 mM EDTA, 2 mM HEPES, pH 7.5, with protease inhibitors followed by centrifugation at 17,000 ϫ g for 35 min. The final pellets were resuspended in buffer containing 40 mM HEPES, pH 7.5, 2.5 mM Ca 2ϩ , and protease inhibitors. Binding was performed as described (32) .
Fluorescent Measurements of Intracellular Ca 2ϩ -For whole cell measurements, mGlu5 expressing HEK cells were grown on glass coverslips in 35-mm Petri dishes overnight, washed with serum-free medium (SFM), and incubated with 10 M Oregon Green 488 BAPTA-1 AM/0.00l% pluronic acid (Molecular Probes) in SFM for 1 h at 37°C. Cells were washed three times with SFM and then imaged in real time using an Olympus Fluoview laser scanning confocal microscope. Drugs at 100ϫ concentrations were added to the side of the dish and allowed to diffuse over the cells at room temperature. Glutamate was added at a final concentration of 1 mM, the mGlu5-specific antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP; Tocris) at 1 M, the muscarinic agonist, carbachol, at 1 mM, and the glutamate transport blockers, DL-threo-␤-benzoxylaspartate (TBOA) at 1, 10, and 100 M and threo-␤-OH-aspartic acid (TEA; Sigma) at 100 M final concentration. In some experiments after dye loading, SFM was replaced with a standard ringers solution in which choline was substituted for sodium (138 mM choline, 4 mM KCl, 10 mM HEPES, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM glucose, pH 7.25).
For whole cell measurements of SFV-transduced midbrain cultures, cells plated on glass ovals with grids were maintained in Neurobasal media until DIV 7 when they were transduced with SFV-mGlu5 or SFV-Pael-R viral particles at an MOI of 1 for 60 min. SFV-Pael-R served as a non-mGlu5-related control. Cells were subsequently allowed to recover and express foreign gene product for 5 h prior to being loaded with Oregon Green BAPTA and imaged as described above.
To measure Ca 2ϩ changes in individual nuclei, cells were plated at low density on 35-mM glass bottom, dishes with grids, and grown overnight. Cells were loaded with Oregon Green BAPTA as above, washed with SFM and then phosphate-buffered saline. Dishes were placed on ice and covered with medium containing 0.125 M sucrose, 2.0 mM MgCl 2 , 25 mM KCl, 10 mM HEPES (pH 7.5), and protease inhibitors for 10 min. These conditions were empirically found to gently lyse plasma cell membranes while leaving nuclear membranes intact and nuclei attached to the dish. Subsequently, the lysing medium was removed, and cells were washed three times with phosphate-buffered saline and then SFM. Nuclei were imaged immediately thereafter. Drug treatments were identical to whole cells. Following image collection, cells/nuclei were fixed, stained, with anti-mGlu5 and/or lamin B 2 , and field relocated to verify nuclear designations.
RESULTS

mGlu1 Receptors Are Localized at Both the Nuclear and
Plasma Membranes-Electron microscopic analyses have revealed Group l mGlu receptors on nuclear and ER membranes (36 -38) . To establish a system in which nuclear receptor function could be addressed, cDNAs for each receptor were transiently transfected into a variety of cell types including human embryonic kidney (HEK) cells. Antibodies against the C-terminal portion of the mGlu5 protein stained the plasma membrane as well as ER and nuclear membranes in transiently transfected ( Fig. 1 ) and stable HEK cell lines (Fig. 2B ). Nuclear localization was determined by co-staining with the nuclear membrane marker lamin B 2 ( Fig. 1) . In contrast, GABA B2 was predominately localized at the plasma membrane (Fig. 1B) . Ryanodine receptor family members are expressed in the ER as well as nuclear membranes (48) . Anti-ryanodine receptor-2 co-localized with mGlu5 around the nuclear membrane (Fig.  1C) . Treatment with 1 mM glutamate or baclofen did not produce an obvious re-distribution of receptor subtypes in these cultures (not shown). Naive HEK cells or ones expressing unrelated receptors never exhibited mGlu5 immunoreactivity (Ref. 44 and not shown)
To confirm the presence of mGlu5 on the nuclear membrane, conditions were used in which the plasma membrane was briefly permeabilized with digitonin (43) . Cells were then fixed and stained (Dig-Fix) or fixed, treated with Triton X-100, and stained (Dig-Fix-Triton). Without Triton X-100 the nuclear envelope and nuclear pore complexes remained intact, restricting antibody access. Thus, inner nuclear proteins such as lamin B 2 were not observed using Dig-Fix conditions versus buffers containing Triton X-100 (Fig. 1D versus Fig. 1E ). This strategy allowed mGlu5 receptors to be clearly visualized at the nuclear membrane in close proximity to lamin B 2 (Fig. 1D) . Because anti-mGlu5 antibodies labeled these receptors in the absence of Triton X-100 (Fig. 1E) , many of these receptors must be on the outer nuclear membrane with their C-terminal domains cytoplasmically accessible. In contrast, the GABA B2 receptor was never seen on the nuclear membrane using either standard fixation or digitonin permeabilization techniques (Fig. 1, B, D , and E). The latter process essentially removed all detectable GABA B2 receptor from the plasma membrane (Fig. 1, D and E) .
FIG. 1. Co-localization of mGlu5 receptors with lamin B 2 . A-C,
HEK-293 cells were transiently transfected with the cDNA for the indicated receptors. After 24 h the cells were washed, fixed, permeabilized, with Triton-X-100 and processed for immunocytochemistry using receptor-specific antibodies as well as anti-lamin B 2 (A, B) or antiryanodine receptor (C). Cells were analyzed by confocal microscopy to detect receptor localization (green) and lamin B 2 or ryanodine receptor distribution (red). Photographs represent single optical sections of 0.4 m merged such that yellow indicates co-localization of the specific antigens. D and E, mGlu5 but not GABA B2 receptor localizes to the nuclear membrane. HEK cells were processed for immunocytochemistry using either the Digitonin-Fix-Triton protocol (D) or Digitonin-Fix (E) and the indicated antibodies. Permeabilization of cells prior to fixing markedly reduced the detection of GABA B2 (D and E). The lack of anti-lamin B 2 staining under Digitonin-Fix conditions shows the lack of antibody accessibility to the nucleus in the absence of Triton-X-100 (E).
FIG. 2. Localization of mGlu5 N terminus to nuclear membranes.
A, N-terminal-tagged mGlu5 receptors are present on nuclear membranes. HEK cells were transiently transfected with the cDNA for HA-tagged mGlu5 and then processed using digitonin permeabilization techniques as indicated. The lack of anti-HA staining under DigitoninFix conditions shows the lack of antibody accessibility to the nuclear lumen in the absence of Triton-X-100. B, anti-mGlu5 labels isolated nuclei from mGlu5 stable cell line. Aliquots of nuclei used for subcellular fractionation were allowed to adhere to a poly-D-lysine-treated coverslip prior to fixation, permeabilization, and incubation with antibodies directed against mGlu5 receptors (green), lamin B 2 (red), or ryanodine receptors (red). Nuclei were analyzed by confocal microscopy. Merged images of single 0.4-m optical sections confirm mGlu5/lamin B 2 co-localization in yellow. C, GFP-tagged G q is widely expressed in transfected HEK cells including the nuclear envelop. HEK cells transiently transfected with GFP-tagged G q were fixed and permeabilized with Triton-X-100 and processed for immunocytochemistry using receptor-specific antibodies as well as anti-GFP.
Identical intracellular localization patterns were observed for mGlu5 and GABA B2 receptors in CHO, PC12, and MN9D cells (not shown). These data suggest that a significant fraction of mGlu5 receptors but not GABA B2 can be expressed on nuclear membranes in heterologous cell types.
Since the antibody used to determine the subcellular localization of mGlu5 was directed against its C terminus, HEK cells were transiently transfected with an N-terminal HAtagged mGlu5 receptor (32) to determine whether the N-terminal portion of the receptor was also co-localized with nuclear membranes. Anti-HA antibodies also showed co-localization of this marker with lamin B 2 ( Fig. 2A) . These data suggest that the entire mGlu5 receptor is present on the nuclear membrane, not just the C terminus. Using digitonin permeabilization techniques, N-terminally tagged mGlu5 receptors were only observed on nuclear membranes in the presence of Triton-X-100 ( Fig. 2A) . This finding suggests that the N terminus of mGlu5 is within the nuclear lumen and thus inaccessible to antibody.
To confirm and extend the nuclear localization of mGlu5, aliquots of HEK nuclei prepared as described below were allowed to adhere to a poly-D-lysine-coated glass disc, fixed and processed for immunohistochemistry. The mGlu5 receptor staining co-localized with lamin B 2 as well as the ryanodine receptor (Fig. 2B) . Staining was confined essentially to the periphery of the nucleus or in regions of the endoplasmic reticulum adjacent to it. These results further corroborate the whole cell staining showing the presence of mGlu5 receptors on intracellular membranes. Group l mGlu receptors couple preferentially to G q/11 proteins leading to the activation of PLC and subsequent Ca 2ϩ mobilization. Hughes et al. (49) have reported G q to be present on nuclear membranes. The presence of GFP-tagged G q on nuclear membranes was confirmed in these studies (Fig. 2C) . Collectively, both mGlu5 receptors as well as their effector proteins can be localized to nuclear membranes.
Nuclear and Plasma Membrane mGlu5 Receptors Exhibit Similar Binding Characteristics-To confirm the co-localization of mGlu5 with nuclear membranes and to extend this observation in vivo, subcellular fractionation experiments were performed using an mGlu5/HEK stable cell line (45) as well as postnatal day 3 (P3) cortical tissues. In either case, the mGlu5 receptor was clearly expressed in both nuclear and plasma membrane fractions as indicated by membrane-specific markers, lamin B 2 , and Na ϩ ,K ϩ -ATPase, respectively (Fig. 3 ). To determine whether nuclear receptors exhibited similar binding characteristics as did plasma membrane receptors, binding studies using [ 3 H]quisqualate as a radioligand were performed on the same cortical fractions used for Western blotting (Fig. 3) . The ability of quisqualate or the endogenous ligand, glutamate, to inhibit shows that mGlu5 receptor can be detected in fractions containing both the nuclear (N) and plasma membranes (PM). Thirty micrograms of protein from each fraction were separated on reducing SDS gels and transferred to nylon membranes. The same blot was sequentially probed with antibodies against mGlu5, the inner nuclear marker, lamin B 2 , and the plasma membrane marker, Na ϩ ,K ϩ -ATPase.
FIG. 4. Embryonic mesencephalic and adult cortical neurons exhibit nuclear mGlu5 localization.
A, primary cultures of mesencephalic neurons were transduced with SFV(PD)-mGlu5 viral particles at an MOI of 1. Virus was removed 1 h later and cultures were allowed to recover for 16 h before being fixed and stained for mGlu5 (green) or lamin B 2 (red). Merged images reveal areas of co-localization (yellow). B and C, electron micrographs of mGlu5 receptor immunogold labeling in rat visual cortex. Immunogold particles (black dots) are associated with postsynaptic density (PSD) of asymmetric synapse (B) as well as inner (IN) and outer nuclear (ON) membranes and rough ER (C) from the same preparation. AT, axon terminal; D, dendrite.
nuclear membranes exhibited IC 50 values of 0.94 Ϯ 0.23 M and 3.26 Ϯ 0.97 M, respectively. Inasmuch as nuclear receptors can bind agonist and display similar rank order potencies for glutamate and quisqualate, it would appear that they are correctly folded and inserted into the nuclear envelope.
Embryonic Mesencephalic and Adult Cortical Neurons Exhibit Nuclear mGlu5
Localization-Although associated with synaptic membranes in a variety of brain regions, Hubert et al., (36) described a predominately intracellular pattern of expression for mGlu5 in neurons from rat and monkey substantia nigra. To test whether mGlu5 expression was apparent in primary cultures of mouse mesencephalon, dissociated neurons derived from embryonic day 14 mouse pups were grown in vitro for 10 days and then stained for mGlu5. At this developmental time point no obvious mGlu5 staining was observed (not shown). Sibling cultures were then transduced at an MOI of 1 for 1 h with a SFV vector driving mGlu5 expression. Viral particles were removed and cells allowed to recover overnight. Cultures were subsequently fixed and stained for mGlu5 and lamin B 2 . mGlu5 expression was observed in soma and dendrites as well as at nuclear membranes (Fig. 4A) .
In other studies immunogold staining with antibodies di- rected against the C-terminal portion of mGlu5 was used to assess the subcellular location of this receptor in rat visual cortex. Immunogold particles were associated with postsynaptic densities of asymmetrical (excitatory) synapses (Fig. 4B) as well as rough ER and nuclear membranes (Fig. 4C) . These data confirm and extend the observations of Hubert et al. (36) indicating that mGlu5 can be expressed on nuclear membranes in embryonic and adult neurons as well as heterologous cell types.
Glutamate Green BAPTA whose spatio-temporal distribution was analyzed in the confocal microscope. Oregon Green BAPTA exhibited a relatively homogeneous distribution throughout both the cytoplasm and nucleoplasm (Fig. 5A) . When glutamate was bath-applied, Ca 2ϩ oscillations were observed in both intracellular compartments (Fig. 5, A-C) . Both sets of fluctuations were blocked with the addition of the antagonist, MPEP (1 M). Fig. 5D represents compiled data from multiple experiments. Addition of carbachol led to a cytosolic rise in Ca 2ϩ but not to increased nuclear Ca 2ϩ (Figs. 5E and 6D) . Moreover, activation of the endogenous muscarinic receptor never led to intracellular Ca 2ϩ oscillations (Fig. 5E and Ref. 32) . Bath application of glutamate to non-transfected HEK cells had no effect (Fig. 5G) . These data are consistent with nuclear mGlu5 receptors coupling to G proteins localized on nuclear membranes but they do not rule out the possibility that the observed Ca 2ϩ fluctuations are due to other, indirect causes. 
Direct Activation of Nuclear mGlu5 Receptors Triggers Nuclear Ca
2ϩ Oscillations-To determine whether mGlu5 receptors present on the nuclear membrane could directly induce nuclear Ca 2ϩ oscillations, cells were grown on dishes with grids, loaded with Oregon Green BAPTA, and then hypotonically shocked in situ. Isolated nuclei were initially identified by morphology and subsequently confirmed by lamin B 2 staining and field relocation (Fig. 6A) . Bath-application of 1 mM glutamate elicited an oscillatory Ca 2ϩ response that could be blocked by the addition of 1 M MPEP (Fig. 6, A-C) or 0.2 mM EGTA (not shown). The mGlu5-mediated Ca 2ϩ oscillations lasted for at least 5 min although of diminishing intensity. Carbachol did not elicit a nuclear Ca 2ϩ response (Fig. 6D) . Glutamate treatment of non-mGlu5 receptor expressing HEK cells did not elicit a response (Fig. 6E ). These data demonstrate that nuclear mGlu5 receptors couple to functional nuclear G proteins to increase nuclear Ca 2ϩ levels. Several studies have suggested that bivalent cations like Ca 2ϩ affect Group I mGlu receptors (26 -28) . Conceivably, increased cytosolic Ca 2ϩ levels due to activation of plasma membrane mGlu5 receptors activate nuclear mGlu5 receptors in turn perhaps via entry through nuclear Ca 2ϩ -ATPase carriers and/or IP 4 receptors. However, as shown above, no nuclear oscillations were observed in stably transfected mGlu5/HEK cells treated with carbachol despite increased cytosolic Ca 2ϩ ( Fig. 5E and 6D) . Similarly, no nuclear oscillations were seen in mGlu5-expressing HEK cells loaded with caged Ca 2ϩ after uncaging (not shown). Collectively, these experiments indicate that increased cytosolic Ca 2ϩ per se does not activate nuclear mGlu5 receptors.
To test the idea that glutamate entering via endogenous glutamate transporters (EAAT3 and Ref. 50) could activate nuclear receptors, sodium-containing ringer solutions were replaced with choline-substituted buffers. Thus, sodium-dependent glutamate transporters such as EAAT3 would be nonfunctional in its absence (51) . Despite the lack of Na ϩ both cytosolic (not shown) and nuclear compartments exhibited glutamate-induced Ca 2ϩ fluctuations (Fig. 5F ). Similarly transport inhibitors such as TBOA or TEA did not block glutamate-induced oscillations either (not shown). Although sodium-independent transporters and/or other carriers remain a possibility, these data suggest that sodium-dependent plasma membrane glutamate transporter activity is not responsible for nuclear mGlu5 receptor activation.
Besides G q/11 , Group l mGlu receptors have also been shown to couple to G s or G i/o proteins in various model systems. Preliminary experiments treating mGlu5-expressing HEK cells with pertussis toxin overnight did not block glutamateinduced cytoplasmic or nuclear oscillations (n ϭ 4, not shown) thus it seems unlikely that G i/o proteins play a major role in the observed response.
Activation of mGlu5-expressing Neurons Also Triggers Cytosolic and Nuclear Ca
2ϩ Oscillations-To extend these studies to neurons, primary mesencephalic cultures grown on glass coverslips with grids were transduced with the SFV vector driving mGlu5 expression. SFV is known to exhibit a marked preference for neurons in vitro and in vivo (90 -95%; 41). SFVtransduced midbrain cultures similarly expressed viral particles only in cell types that co-stained with the neuronal marker, NeuN, not with the astrocytic marker, GFAP (not shown). Cultures loaded with Oregon Green BAPTA were analyzed as before. Cells were subsequently fixed, stained for mGlu5 and field-relocated to assess specificity of response. As in HEK cells, mGlu5-transduced neurons exhibited Ca 2ϩ oscillations in both nuclear and cytoplasmic compartments in response to bathapplied glutamate (Fig. 7) . In contrast, bath application of glutamate to non-transduced cultures led to single, transient intracellular Ca 2ϩ rises in many neurons but not to the oscillatory patterns observed in mGlu5 transduced cells (not shown). Application of glutamate had no effect on cultures transduced with an un-related receptor (Pael-R; Fig. 7E )) or on non-transduced controls (not shown). Thus, these data confirm and extend the results from heterologous cell types indicating that neuronal mGlu5 receptors expressed on nuclear membranes can trigger large, sustained oscillatory Ca 2ϩ responses.
DISCUSSION
Although nuclear Ca 2ϩ plays a critical role in many cellular functions such as apoptosis and gene transcription, its regulation remains unclear. The present study shows that the metabotropic receptor mGlu5 can be expressed on nuclear membranes where it can couple with endogenous signaling components to induce changes in nuclear Ca 2ϩ . Glutamate-induced Ca 2ϩ oscillations can be blocked by the mGlu5 specific antagonist, MPEP, as well as by Ca 2ϩ chelation. Thus, besides being regulated by external signals and intracellular stores, nuclear Ca 2ϩ can also be regulated in situ by G-protein-coupled receptors.
The functionality of nuclear mGlu5 receptors is supported by a number of observations. First, purified nuclear membranes from HEK or cortical cell types bound radiolabeled quisqualate, the Group I-specific agonist. Second, glutamate-treated intact cells exhibited Ca 2ϩ oscillatory patterns in the cytoplasm and the nucleus that could be blocked by the mGlu5 antagonist, MPEP (Fig. 5) . Third, direct stimulation of isolated nuclei from mGlu5 expressing cells but not non-expressing cells induced nuclear Ca 2ϩ oscillations that could also be blocked by MPEP (Fig. 6) . Fourth, nuclear Ca 2ϩ oscillations were specific since carbachol stimulation of endogenous muscarinic receptors did not induce this pattern of Ca 2ϩ release. Fifth, glutamate-induced nuclear Ca 2ϩ oscillations also occurred in mGlu5-transduced neurons demonstrating a physiological role for this phenomenon (Fig. 7) . Taken together, these findings suggest a major role for nuclear mGlu5 receptors in the regulation of nuclear Ca 2ϩ . Activation of Nuclear Receptors-Because the luminal side of the ER corresponds to the extracellular side of the plasma membrane, the mGlu5 receptor topology is predicted to be such that ligand binding domains are within the lumen of the nuclear envelop (Fig. 8) . This interpretation is supported by data obtained by differential permeabilization indicating that while some receptors co-localize with lamin B2 (Fig. 1D ) others are cytoplasmically accessible (Fig. 1E) . Moreover, the in accessibility of the N-terminal-tagged mGlu5 receptor to antibodies in the absence of Triton-X-100 further supports this model ( Fig.  2A) . This notion is also consistent with electron microscopic images from neurons showing that immunogold labeling directed against the mGlu5 C-terminal cytoplasmic tail is present not only at synapses (Fig. 4B) but also on the outside of ER/nuclear membranes and the nucleoplasmic face of the inner nuclear membrane (Fig. 4C) . Given the many studies documenting the occurrence and directionality of the IP 3 and ryanodine receptors on the inner nuclear membrane (8, 48) as well as the existence of a nuclear phosphoinositol cycle (13, 12) , mGlu5 receptors oriented in the latter fashion would be ideally situated to activate nuclear PLC/IP 3 /Ca 2ϩ cascades. The question arises then as to what ligand activates these receptors and how does it do so. The Group I mGlu receptors are homologous to the Ca 2ϩ -sensing receptors, which are activated by bivalent cations (24) . Indeed a number of studies (26 -28) although not all (29) have shown that mGlu receptormediated functions can be affected by alterations in extracellular Ca 2ϩ concentrations. However, the proposed luminal binding sites would already be exposed to several hundred micromolar Ca 2ϩ due to the continuous nature of the ER/ nuclear lumen (3). Moreover, activation of mGlu5 cell surface receptors leads to the loss of luminal stores, not increased ER Ca 2ϩ . Finally, neither uncaging Ca 2ϩ nor increasing cytoplasmic levels via activation of muscarinic receptors led to nuclear oscillations (Fig. 5E ). Thus, it seems unlikely that Ca 2ϩ per se activates nuclear receptors.
As the natural ligand, glutamate itself may activate intracellular receptors. Glutamate uptake is mediated by at least five sodium-dependent transporter proteins that are present on the plasma membrane of glial and neuronal cells as well as many peripheral tissues including pancreas and kidney (51) . Many other glutamate carriers exist, however, including sodium-independent plasma membrane transporters (52) as well as chloride-dependent uptake systems (53) , and various heteroexchangers (54). Intracellular glutamate carriers also abound including mitochondrial (55) and vesicular transporters (56) as well as intracellular pools of plasma membrane transporters (57) . In theory, some combination of plasma membrane and intracellular transporter could transfer glutamate into the ER lumen.
Previous studies have shown that HEK cells endogenously express the EAAT3 glutamate transporter subtype (50 extracellular glutamate uptake via the endogenous transporter. Current data, however, does not support this hypothesis since transporter inhibitors such as TBOA or AP-4 had no effect on agonist-mediated nuclear Ca 2ϩ oscillations. Moreover, replacement of sodium, which is required for glutamate transporter activity, did not block nuclear Ca 2ϩ oscillations either (Fig. 5F ). Hence it seems unlikely in these cells that extracellular glutamate activates nuclear mGlu5 receptors via high affinity, sodium-dependent glutamate transporters.
Glutamate is involved in intermediary metabolism as well as neurotransmission. In neurons, for example, intracellular glutamate levels have been estimated at about 10 mM rising to 100 -200 mM within glutamatergic vesicles (58, 51) . Moreover, glutamate formation from its precursor glutamine plays a pivotal regulatory role in many cellular processes (59) . Recent data have also implicated glutamate as an intracellular messenger in the regulation of insulin secretion (EC 50 , 2-6 mM; Refs. 60 and 61) as well as in the regulation of glutamate transporter cell surface expression (62) . Conceivably, activation of plasma membrane mGlu5 receptors could trigger adaptive responses that lead to increased intracellular glutamate formation and/or mobilization, which activate nuclear mGlu5 receptors in turn. Pharmacological manipulation of key enzymes involved in glutamine conversion to glutamate and/or other glutamate carriers may help define nuclear mGlu5 ligand formation.
Many studies have shown that the in vivo trafficking of Group 1 mGlu receptors is dynamically modulated by Homer proteins (63, 64) . For example, some Homer subtypes can prevent cell surface expression of Group 1 receptors whereas others can promote trafficking to specific membrane destinations (63, 64) . Homer interactions can even lead to agonist-independent receptor activation (65) . Thus potentially Homer family members could not only influence the cellular localization of mGlu 1/5 receptors but might also serve as perfectly positioned (cytoplasmic) activators of that function. Studies are currently under way to address these hypotheses.
Nuclear GPCRs-In the last few years the roster of nuclear signaling components has become extensive including heterotrimeric G proteins themselves as well as many of their effector molecules (18) . Despite the presence of signal transduction machinery, few GPCRs have been described on nuclear membranes, most with unknown physiological relevance. Recently, however, PGE2 receptors have been found on the nuclear envelope (22, 23) together with their ligand-generating enzymes. Nuclear effects of ligand stimulation of these receptors included induction of immediate-early genes such as c-fos as well as the regulation of endothelial nitric-oxide synthase (eNOS) expression in endothelial cells (22, 23) . The physiological relevance of nuclear PGE2 receptors was also strengthened by experiments demonstrating the requirement of plasma membrane prostaglandin transporters for receptor activation (22) . These data support the notion that uptake via cell surface transporters contributes to signaling by activation of intracellular receptors.
Glutamate transporters are located on astrocytes where they participate in the glutamate/glutamine cycle, and are located postsynaptically (51) . For example, the glutamate transporter, EAAT4, is highly enriched on Purkinje cell spines (66) where it is thought to modulate postsynaptic excitation (67, 68) . Similarly, EAAC1 is associated with dendritic spines and shafts in the CA1 region of the hippocampus (57) . Because Group 1 mGlu receptors exhibit overlapping distributions with these transporters in the cerebellum (mGlu1) and hippocampus (mGlu5; Ref. 63 ) it is conceivable that glutamate uptake serves many purposes including signal termination, modulation of firing, as well as activation of extra and intracellular mGlu receptors. It is worth noting that both EAAC1 (57) and EAAT4 (66) are associated with intracellular membranes as well. Thus, transport systems are already in place in vivo that are poised to deliver ligand to intracellular receptors.
In conclusion, contrary to the idea that intracellular mGlu5 receptors are non-functional and merely constitute an internal reserve of receptors waiting to go to the cell surface, the present data argue strongly for a dynamic intracellular role in signal transduction. Given that the ER, nuclear lumen and mitochondria all serve as unique intracellular stores of Ca 2ϩ , intracellular receptors such as mGlu5 may play a pivotal role in generating and shaping intracellular Ca 2ϩ signals.
